Wellness Bio Radar
Nutritional science, metabolic research and dietary strategies supported by peer-reviewed evidence.
193 articles
Researchers at a recent study published in May 2026, explored the connection between the liver and microbiome, shedding new light on the role of food in liver health. The study was conducted by a…
The US FDA has given the green light to the first over-the-counter integrated continuous glucose monitor for consumers, including children. This clearance was announced on June 15, 2026. The device,…
Researchers at Monash University have made a breakthrough in laboratory experiments, discovering a copper-delivering drug that improves cognitive function and spatial learning. The study was…
New research highlights how internal body clocks dictate muscle maintenance efficiency. Studies indicate night owls face higher risks of muscle loss and metabolic issues compared to early risers due…
Researchers are investigating how certain legumes can inhibit the enzymes that enable cancer to become invasive. Cancer treatment costs are rising, with expenditures expected to increase…
The Food and Drug Administration announced a voluntary recall of nearly 3,000 bottles of a cholesterol‑lowering drug on June 11, 2026. The product, marketed to balance LDL, HDL, and triglyceride…
Researchers presented findings at the European Hematology Association conference on a chemotherapy-free treatment for pediatric patients with a rare and aggressive blood cancer. The study involved…
Registered dietitians are speaking out against misinformation spreading online about certain foods and diets. The experts are urging people to be cautious of false claims. This comes as social media…
Researchers at the Center for Genomic Regulation have made a groundbreaking discovery about collagen, the human body's most abundant protein. Collagen is a crucial component of skin, bones, tendons,…
Physician-scientists at Kanazawa University have made a breakthrough in treating ultra-rare urachal cancer. They demonstrated the clinical efficacy of chemoimmunotherapy in patients with this…
Researchers are re-examining treatment approaches for early-stage triple-negative breast cancer (TNBC) as the disease's treatment landscape continues to evolve. Triple-negative breast cancer is a…
A new drug called apitegromab is being tested to counteract muscle loss linked to GLP‑1 weight‑loss medicines. The phase‑2 study, led by researchers at several U.S. academic centers, began enrolling…